All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0323-LX360 | Anti-CXCL11 VHH(X3XH360) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH360 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX361 | Anti-CXCL11 VHH(X3XH361) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH361 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX362 | Anti-CXCL11 VHH(X3XH362) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH362 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX363 | Anti-CXCL11 VHH(X3XH363) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH363 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX364 | Anti-CXCL11 VHH(X3XH364) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH364 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX365 | Anti-CXCL11 VHH(X3XH365) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH365 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX366 | Anti-CXCL11 VHH(X3XH366) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH366 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX367 | Anti-CXCL11 VHH(X3XH367) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH367 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX368 | Anti-CXCL11 VHH(X3XH368) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH368 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX727 | Anti-CXCL11 VHH(X3XH358) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH358 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX728 | Anti-CXCL11 VHH(X3XH359) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH359 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX729 | Anti-CXCL11 VHH(X3XH360) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH360 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX730 | Anti-CXCL11 VHH(X3XH361) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH361 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX731 | Anti-CXCL11 VHH(X3XH362) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH362 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX732 | Anti-CXCL11 VHH(X3XH363) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH363 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX733 | Anti-CXCL11 VHH(X3XH364) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH364 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1103 | Anti-CXCL11 VHH(X3XH365) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH365 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1104 | Anti-CXCL11 VHH(X3XH366) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH366 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1105 | Anti-CXCL11 VHH(X3XH367) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH367 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1106 | Anti-CXCL11 VHH(X3XH368) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH368 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0823-LX33 | Anti-hCXCL11 (E6) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | E6 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION